KU Cancer Center launches clinical trial to eliminate radiation therapy for HER2-posi
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the treatment protocol for an invasive type of breast cancer that accounts for one-fifth of all breast cancer patients.